Chinese Traditional and Herbal Drugs
|
2025, 56(20): 7564-7580
Mechanism of action and clinical application progress of Xiaoyao San and its core modified prescriptions in treatment of malignant tumors
Full
ZHU Ranpei, MA Qinghai, ZHANG Pingxin, WANG Yingrui, ZHENG Yuling
Affiliations
doi: 10.7501/j.issn.0253-2670.2025.20.026
Outline
Xiaoyao San (逍遥散), derived from Formulary of the Bureau of Taiping People’s Welfare Pharmacy, possesses the effects of soothing the liver, strengthening the spleen, nourishing blood, regulating qi, and calming the mind. Initially formulated for gynecological diseases, it has since derived a series of modified prescriptions such as Hei Xiaoyao San (黑逍遥散) and Danzhi XiaoYao San (丹栀逍遥散) based on its core composition, with applications extended from gynecology to multiple disciplines. In recent years, increasing research has focused on its use in treating tumors and related conditions. This article systematically reviews the value of Xiaoyao San in malignant tumors from three aspects: formula-syndrome analysis, mechanism research, and clinical application. It is found that the core prescription focuses on “harmonizing” and “soothing”, with both the functions of strengthening healthy qi and eliminating pathogenic factors. Mechanistically, it exerts anti-tumor effects by regulating tumor cell proliferation, autophagy, apoptosis, tumor microenvironment, exosomes, and metabolic reprogramming, with clear molecular mechanisms verified by in vivo and in vitro experiments. Clinically, it can block precancerous lesions, enhance efficacy and reduce toxicity when combined with conventional Western therapies, improve the quality of life of end-stage patients, and has definite curative effects on tumor-related complications such as depression and insomnia. It is highly safe and suitable for long-term use by tumor patients. This review provides references for the clinical promotion of Xiaoyao San and its core modified prescriptions, the collaboration between traditional Chinese and Western medicine, and the development of antitumor drugs.
Xiaoyao San
/
malignant tumors
/
breast cancer
/
liver cancer
/
tumor-related complications
/
tumor cell proliferation
/
tumor microenvironment
朱燃培, 马清海, 张萍心, 王颖睿, 郑玉玲.
逍遥散及其核心加减方治疗恶性肿瘤的作用机制及临床应用进展.
中草药,
2025
, 56
(20)
: 7564
-7580
.
DOI: 10.7501/j.issn.0253-2670.2025.20.026
ZHU Ranpei, MA Qinghai, ZHANG Pingxin, WANG Yingrui, ZHENG Yuling.
Mechanism of action and clinical application progress of Xiaoyao San and its core modified prescriptions in treatment of malignant tumors[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(20)
: 7564
-7580
.
DOI: 10.7501/j.issn.0253-2670.2025.20.026
Year 2025 volume 56 Issue 20
60
12
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.20.026
- Receive Date:2025-06-20
- Online Date:2026-11-13